Bellevue Group Ag Relay Therapeutics, Inc. Transaction History

Bellevue Group Ag

$4.39 Billion
Q2 2025

A detailed history of Bellevue Group Ag transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 8,230,870 shares of RLAY stock, worth $33.4 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

8,230,870

Previous 7,377,292 11.57%

Holding current value

$33.4 Million

Previous $19.3 Million 47.34%

% of portfolio

0.65%

Previous 0.45%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.0 - $3.49 $1.71 Million - $2.98 Million	853,578 Added 11.57%	8,230,870 $28.5 Million
Q4 2024 Feb 14, 2025	BUY	$4.12 - $6.8 $444 - $734	108 Added 0.0%	7,377,292 $30.4 Million
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $6.23 Million - $9.51 Million	1,000,069 Added 15.68%	7,377,184 $52.2 Million
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $2.66 Million - $3.61 Million	450,497 Added 7.6%	6,377,115 $41.6 Million
Q1 2024 May 15, 2024	SELL	$7.5 - $12.07 $70,980 - $114,230	-9,464 Reduced 0.16%	5,926,618 $49.2 Million
Q4 2023 Feb 14, 2024	BUY	$6.01 - $11.48 $6.32 Million - $12.1 Million	1,051,082 Added 21.52%	5,936,082 $65.4 Million
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $5.89 Million - $9.26 Million	714,200 Added 17.12%	4,885,000 $41.1 Million
Q2 2023 Aug 14, 2023	SELL	$9.99 - $18.27 $17,982 - $32,886	-1,800 Reduced 0.04%	4,170,800 $52.4 Million
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $483,300 - $733,327	-32,220 Reduced 0.77%	4,172,600 $68.7 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $3.12 Million - $5.41 Million	172,558 Added 4.28%	4,204,820 $94.1 Million
Q2 2022 Aug 11, 2022	BUY	$13.31 - $34.88 $1.51 Million - $3.95 Million	113,300 Added 2.89%	4,032,262 $67.5 Million
Q1 2022 May 13, 2022	SELL	$20.26 - $32.36 $3.79 Million - $6.05 Million	-187,000 Reduced 4.55%	3,918,962 $117 Million
Q4 2021 Feb 10, 2022	BUY	$26.0 - $37.03 $9.1 Million - $13 Million	350,000 Added 9.32%	4,105,962 $126 Million
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $33.2 Million - $42.4 Million	1,115,000 Added 42.22%	3,755,962 $118 Million
Q2 2021 Aug 12, 2021	BUY	$27.5 - $38.19 $19.5 Million - $27.1 Million	709,618 Added 36.74%	2,640,962 $96.6 Million
Q1 2021 May 12, 2021	BUY	$32.52 - $61.53 $17 Million - $32.1 Million	521,987 Added 37.04%	1,931,344 $66.8 Million
Q4 2020 Feb 16, 2021	BUY	$35.51 - $54.03 $3.88 Million - $5.91 Million	109,357 Added 8.41%	1,409,357 $58.6 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $42.7 Million - $58.6 Million	1,300,000 New	1,300,000 $55.4 Million

Others Institutions Holding RLAY

# of Institutions

214

Shares Held

173M

Call Options Held

Put Options Held

36.1K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $488M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Relay Therapeutics, Inc. Transaction History